Publications
496
Citations
7,967
Est. group size
—
Recurring co-author estimate
Active years
34
Publishing since 1993
Susan Tsai's research centers on pancreatic cancer, particularly pancreatic ductal adenocarcinoma, examining tumor biology (such as KRAS mutations and RAS signaling), biomarkers for early detection and monitoring, and clinical/surgical outcomes including treatment resistance and perioperative care. The work spans laboratory-based cancer genomics as well as clinical and health services research, including surgical outcomes and drug therapy comparisons.
Publication output was fairly steady from 2017-2022, spiked sharply in 2023, and has since declined toward more typical yearly levels through 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure 2 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Supplementary Figure 3 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Supplementary Table 1 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Supplementary Figure 4 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Data from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Supplementary Table 2 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Supplementary Figure 1 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRAS<sup>G12R</sup> Pancreatic Ductal Adenocarcinoma
2026
- Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma
Cancer Research · 2025
- Piperacillin-tazobactam versus cefoxitin as perioperative prophylaxis for pancreatoduodenectomy: real world evidence from the EPIC Cosmos database
HPB · 2025
- Impact of Academic Medical Centers on Surgical Outcomes of Neighboring Nonacademic Medical Centers
Journal of the American College of Surgeons · 2025
- Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma
British Journal of Cancer · 2025
- The impact of obtaining explicit informed consent for medical student participation in the pelvic examination under anesthesia: A qualitative interview study
International Journal of Gynecology & Obstetrics · 2025
- Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods
npj Precision Oncology · 2025
- Correction: p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis
Cancer Research · 2025
- Journal of Clinical Oncology×31
- HPB×29
- Cancer Research×20
- Annals of Surgical Oncology×16
- Journal of Surgical Oncology×13
- Ashish Manne
Medicine · The Ohio State University
- Susan Tsai
Medicine · The Ohio State University
- Ankur Sheel
Medicine · The Ohio State University
- Matthew J. Weiss
Medicine · The Ohio State University
- Sean P. Cleary
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile